AMINOMALONIC ACID AND THE CALCIFICATION OF PROTEIN
AMINOMALONIC ACID AND THE CALCIFICATION OF PROTEIN
批准号:
3354958
负责人:
TAD H KOCH
金额:
$6.92万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1986
资助国家:
美国
项目状态:
已结题
起止时间:
1986-12-01 至 1989-11-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Aminomalonic acid has been discovered in alkaline hydrolysates of bacterial
protein, calcified human arterial proteins, and in calcified prosthetic
devices fabricated from bovine pericardium. Based upon preliminary
evidence, the formation of Ama residues in structural proteins is
postulated to be involved in the pathological calcification of these
proteins in diseases such atherosclerosis and in prosthetic devices such as
artificial heart heart valves. More specifically the proposal states 1)
that Ama residues in structural proteins are formed through the
post-translational free radical carboxylation of Gly residues, 2) that Ama
residues, most likely in clusters, serve as binding sites for calcium ions
and consequently, nucleate calcium phosphate crystallization, 3) that the
free radical carboxylations is initiated by radicals from decomposition of
lipid hydroperoxides possibly those present in arterial fatty streaks which
form prior to calcification or by radicals produced by stimulated
phagocytes, and 4) that the calcification of prosthetic devices fabricated
from bovine pericardium can be dramatically inhibited by blocking Ama
formation through the chemical transformation of selected Gly residues to
Ser residues. The specific studies which will be performed are 1) the
synthesis of peptide units containing Ama residues which might logically be
metal binding sites in protein, 2) the determination of the metal binding
properties of these peptides, 3) the determination from model studies of
the formation of Ama residues via free radical induced carboxylation of Gly
residues of structural protein especially type 1 collagen of bovine
percardium utilized to fabricate prosthetic devices, 4) the development of
the method of free radical conversion of exposed Gly residues to Ser
residues for the inhibition of pathological calcification of prosthetic
devices, and 5) establishing that the inhibition is in fact related to the
blocking of in vivo Ama formation. An important health related result will
be the development of a process for the modification of bovine pericardium
which will inhibit the in vivo, pathological calcification of prosthetic
devices for human implant.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Carboxylesterase-activated Doxazolidine-prodrug for Hepatocellular Carcinoma
-
批准号:8307764
-
项目类别:
-
资助金额:$16.48万
-
财政年份:2011
-
负责人:TAD H KOCH
-
依托单位:
Carboxylesterase-activated Doxazolidine-prodrug for Hepatocellular Carcinoma
-
批准号:8184992
-
项目类别:
-
资助金额:$19.77万
-
财政年份:2011
-
负责人:TAD H KOCH
-
依托单位:
Development of a CES 2-Activated Doxazolidine Prodrug for Pancreatic Cancer
-
批准号:7707826
-
项目类别:
-
资助金额:$21.06万
-
财政年份:2009
-
负责人:TAD H KOCH
-
依托单位:
New Drugs Targeted to Metastatic Cancer and Angiogenesis
-
批准号:6634078
-
项目类别:
-
资助金额:$18.79万
-
财政年份:2001
-
负责人:TAD H KOCH
-
依托单位:
New Drugs Targeted to Metastatic Cancer and Angiogenesis
-
批准号:6515170
-
项目类别:
-
资助金额:$18.91万
-
财政年份:2001
-
负责人:TAD H KOCH
-
依托单位:
New Drugs Targeted to Metastatic Cancer and Angiogenesis
-
批准号:6361790
-
项目类别:
-
资助金额:$22.15万
-
财政年份:2001
-
负责人:TAD H KOCH
-
依托单位:
GLYCOPEPTIDE ANTIBOTIC MECHANISM AND RESISTANCE
-
批准号:2727013
-
项目类别:
-
资助金额:$7.13万
-
财政年份:1998
-
负责人:TAD H KOCH
-
依托单位:
GLYCOPEPTIDE ANTIBOTIC MECHANISM AND RESISTANCE
-
批准号:6328791
-
项目类别:
-
资助金额:$7.13万
-
财政年份:1998
-
负责人:TAD H KOCH
-
依托单位:
GLYCOPEPTIDE ANTIBOTIC MECHANISM AND RESISTANCE
-
批准号:6124113
-
项目类别:
-
资助金额:$7.13万
-
财政年份:1998
-
负责人:TAD H KOCH
-
依托单位:
AMINOMALONIC ACID AND THE CALCIFICATION OF PROTEIN
-
批准号:3354954
-
项目类别:
-
资助金额:$7.35万
-
财政年份:1986
-
负责人:TAD H KOCH
-
依托单位:
AMINOMALONIC ACID AND THE CALCIFICATION OF PROTEIN
-
批准号:3354959
-
项目类别:
-
资助金额:$7.06万
-
财政年份:1986
-
负责人:TAD H KOCH
-
依托单位:
NEW DRUGS TO ALLEVIATE ADRIAMYCIN CARDIOTOXICITY
-
批准号:2087286
-
项目类别:
-
资助金额:$17.22万
-
财政年份:1979
-
负责人:TAD H KOCH
-
依托单位:
NEW DRUGS TO ALLEVIATE ADRIAMYCIN CARDIOTOXICITY
-
批准号:3166540
-
项目类别:
-
资助金额:$14.11万
-
财政年份:1979
-
负责人:TAD H KOCH
-
依托单位:
NEW DRUGS TO ALLEVIATE ADRIAMYCIN CARDIOTOXICITY
-
批准号:2087284
-
项目类别:
-
资助金额:$17.57万
-
财政年份:1979
-
负责人:TAD H KOCH
-
依托单位:
NEW DRUGS TO ALLEVIATE ADRIAMYCIN CARDIOTOXICITY
-
批准号:3166535
-
项目类别:
-
资助金额:$11.73万
-
财政年份:1979
-
负责人:TAD H KOCH
-
依托单位:
NEW DRUGS TO ALLEVIATE ADRIAMYCIN CARDIOTOXICITY
-
批准号:3166533
-
项目类别:
-
资助金额:$15.67万
-
财政年份:1979
-
负责人:TAD H KOCH
-
依托单位:
NEW DRUGS TO ALLEVIATE ADRIAMYCIN CARDIOTOXICITY
-
批准号:3166537
-
项目类别:
-
资助金额:$12.96万
-
财政年份:1979
-
负责人:TAD H KOCH
-
依托单位:
NEW DRUGS TO ALLEVIATE ADRIAMYCIN CARDIOTOXICITY
-
批准号:3166536
-
项目类别:
-
资助金额:$12.62万
-
财政年份:1979
-
负责人:TAD H KOCH
-
依托单位:
NEW DRUGS TO ALLEVIATE ADRIAMYCIN CARDIOTOXICITY
-
批准号:3166539
-
项目类别:
-
资助金额:$13.39万
-
财政年份:1979
-
负责人:TAD H KOCH
-
依托单位:
NEW DRUGS TO ALLEVIATE ADRIAMYCIN CARDIOTOXICITY
-
批准号:3166538
-
项目类别:
-
资助金额:$13.23万
-
财政年份:1979
-
负责人:TAD H KOCH
-
依托单位:
海外基金